Healthcare BPO Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare BPO Market 

5.1. COVID-19 Landscape: Healthcare BPO Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare BPO Market, By Provider Service

8.1. Healthcare BPO Market, by Provider Service, 2023 to 203

2

8.1.1 Revenue Cycle Management

8.1.1.1. Market Revenue and Forecast (A)

8.1.2. Patient Enrolments

8.1.2.1. Market Revenue and Forecast (2020 to 2032)

8.1.3. Patient Care

8.1.3.1. Market Revenue and Forecast (2020 to 2032)

Chapter 9. Global Healthcare BPO Market, By Payer Service

9.1. Healthcare BPO Market, by Payer Service, 2023 to 2032

9.1.1. Claims Management

9.1.1.1. Market Revenue and Forecast (2020 to 2032)

9.1.2. Product Development & Business Acquisition (PDBA)

9.1.2.1. Market Revenue and Forecast (2020 to 2032)

9.1.3. Member Management

9.1.3.1. Market Revenue and Forecast (2020 to 2032)

9.1.4. Provider Management

9.1.4.1. Market Revenue and Forecast (2020 to 2032)

9.1.5. Care Management

9.1.5.1. Market Revenue and Forecast (2020 to 2032)

9.1.6. Integrated Front-End Services and Back-office Operations

9.1.6.1. Market Revenue and Forecast (2020 to 2032)

9.1.7. Billing and accounts management services 

9.1.8.1. Market Revenue and Forecast (2020 to 2032)

9.1.8. HR Services

9.1.8.1. Market Revenue and Forecast (2020 to 2032)

Chapter 10. Global Healthcare BPO Market, By Life Science Service 

10.1. Healthcare BPO Market, by Life Science Service, 2023 to 2032

10.1.1. Manufacturing

10.1.1.1. Market Revenue and Forecast (2020 to 2032)

10.1.2. R&D

10.1.2.1. Market Revenue and Forecast (2020 to 2032)

10.1.3. Non-Clinical Services

10.1.3.1. Market Revenue and Forecast (2020 to 2032)

Chapter 11. Global Healthcare BPO Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.1.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.1.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.1.4.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.1.4.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.1.5.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.1.5.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.2.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.2.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.2.4.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.2.4.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.2.5.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.2.5.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.2.6.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.2.6.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.2.7.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.2.7.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.3.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.3.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.3.4.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.3.4.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.3.5.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.3.5.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.3.6.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.3.6.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.3.7.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.3.7.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.4.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.4.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.4.4.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.4.4.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.4.5.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.4.5.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.4.6.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.4.6.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.4.7.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.4.7.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.5.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.5.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.5.4.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.5.4.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Provider Service (2020 to 2032)

11.5.5.2. Market Revenue and Forecast, by Payer Service (2020 to 2032)

11.5.5.3. Market Revenue and Forecast, by Life Science Service (2020 to 2032)

Chapter 12. Company Profiles

12.1. Accenture (Ireland)

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Access Healthcare (US)

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Akurate Management Solutions (US)

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Cognizant (US)

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Firstsource Solutions (India)

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. GeBBS Healthcare Solutions (US)

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Genpact (US)

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. HCL Technologies (India)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. IBM Corporation (US)

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Infosys BPM (India)

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms